University of Wisconsin, Madison
The purpose of this randomized behavioral clinical trial is to examine whether a well-being intervention can improve both psychological well-being and physical outcomes in adults with Irritable Bowel Syndrome (IBS). The study aims to assess whether this intervention decreases anger, anxiety, and depression; increases self-esteem, empathy, and hope; and improves quality of life indicators such as IBS symptom severity, sleep quality, fatigue, and diet. Participants can expect to be on study for up to 9 months.
This study consists of two phases: Study 1 (Screening and Baseline Assessment): Participants who self-identify as having been diagnosed with IBS and receive care at the University of Wisconsin (UW) Digestive Health Center will complete a battery of self-report questionnaires assessing well-being, anger, anxiety, depression, self-esteem, empathy, hope, sleep quality, fatigue, diet, and IBS symptom severity. Study 2 (Intervention Phase - registered here): Eligible participants will be randomized to either an experimental well-being intervention or a waitlist control condition. Participants a…
Inclusion Criteria: * Men and women currently diagnosed with Irritable Bowel Syndrome (IBS) by a healthcare provider. * Able to read and write in English. * Willing to complete questionnaires and participate in either the intervention or control group. * Capable of providing informed consent. * Must be a UW Health patient or referred through UW Digestive Health Center. Exclusion Criteria: * Individuals with cognitive impairments or reading difficulties that would interfere with understanding study materials or completing assessments. * Individuals unable to provide informed consent. * Prior…
The intervention will be once weekly over a 15-week period, lasting approximately one hour per session.
Arctuva estimate
Verify or correct the compensation shown for this listing.